2. Search Result
Search Result
Results for "

succinimides

" in MedChemExpress (MCE) Product Catalog:

8

Inhibitors & Agonists

1

Fluorescent Dye

2

Biochemical Assay Reagents

1

Isotope-Labeled Compounds

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-41877S
    Succinimide-15N

    		Isotope-Labeled Compounds Others
    Succinimide- 15N is the 15N labeled Succinimide [1].
    <em>Succinimide</em>-15N
  • HY-75200
    N-(Benzyloxycarbonyloxy)succinimide

    		Biochemical Assay Reagents Others
    N-(Benzyloxycarbonyloxy)succinimide is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
    N-(Benzyloxycarbonyloxy)<em>succinimide</em>
  • HY-79647
    Fmoc-OSu

    N-(Fmoc-oxy)succinimide

    		 Biochemical Assay Reagents Others
    N-(9-Fluorenylmethoxycarbonyloxy)succinimide is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
    Fmoc-OSu
  • HY-W048688
    Fmoc-Trp(Me)-OH

    		Amino Acid Derivatives Others
    Fmoc-Trp(Me)-OH is synthesized by N-(9-Fluorenylmethoxycarbonyloxy)succinimide (Fmoc-ONSu) and 1-Methyl-Ltrypthophan and can be used for protein or peptide synthesis .
    Fmoc-Trp(Me)-OH
  • HY-D1352
    Sulfo-Cyanine7 NHS ester potassium

    		Fluorescent Dye Others
    Sulfo-Cyanine7 NHS ester potassium is an amine-reactive succinimide ester. Sulfo-Cyanine7 NHS ester reagent allows to prepare sulfo-Cyanine7-labeled biomolecules, such as proteins, with ease. Dye labeled molecules can be subsequently used for various research and agent design related experiments.
    Sulfo-Cyanine7 NHS ester potassium
  • HY-B1730
    Phensuximide
    1 Publications Verification
    Phensuximide is an orally active succinimide antiepileptic and anticonvulsant agent. Phensuximide inhibits cyclic AMP and cyclic GMP accumulation in depolarized brain tissue. Phensuximide can be used for the study of seizure and petit mal .
    Phensuximide
  • HY-148459
    ATAC21

    		Drug-Linker Conjugates for ADC Cancer
    ATAC21, a linker-immune-stimulatory compound that can be formed by conjugating a noncleavable maleimide-PEG4 linker containing a succinimide group with an immune- stimulatory compound. ATAC21 can be combined with SBT-040 (anti-CD40 antibody) to form a conjugate .
    ATAC21
  • HY-15314
    Ranirestat
    1 Publications Verification

    AS-3201

    		 Aldose Reductase Neurological Disease Metabolic Disease
    Ranirestat (AS-3201) potent and orally active aldose reductase (AR) inhibitor with IC50s of 11 nM and 15 nM for rat lens AR and recombinant human AR, respectively, and a Ki of 0.38 nM for recombinant human AR. Ranirestat has the potential for diabetic sensorimotor polyneuropathy treatment. Ranirestat also has a neuroprotective effect on diabetic retinas .
    Ranirestat

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: